Moreover, cancer cell behavior is remarkably malleable when the level of GCIP is modulated: GCIP expression can potentially reduce metastatic properties, such as MEK-ERK signaling, whereas its knockdown may augment these properties. Here, CCNDBP1 is linked to cancer.